Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
134.72B | 130.04B | 122.75B | 137.65B | 136.01B | 126.56B | Gross Profit |
38.59B | 37.20B | 35.16B | 36.77B | 35.87B | 32.84B | EBIT |
5.84B | 5.71B | 4.38B | 5.90B | 5.74B | 4.29B | EBITDA |
6.31B | 7.42B | 6.05B | 7.49B | 7.33B | 5.97B | Net Income Common Stockholders |
3.63B | 3.58B | 1.61B | 3.90B | 1.55B | 2.41B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
15.22B | 12.69B | 9.04B | 11.58B | 10.62B | 5.72B | Total Assets |
58.55B | 52.18B | 47.34B | 48.69B | 47.21B | 41.52B | Total Debt |
13.67B | 11.80B | 11.64B | 12.19B | 13.42B | 12.06B | Net Debt |
-1.55B | -894.00M | 2.60B | 603.00M | 2.80B | 6.35B | Total Liabilities |
32.93B | 28.91B | 27.28B | 29.14B | 30.95B | 26.73B | Stockholders Equity |
25.62B | 23.27B | 20.06B | 19.54B | 16.26B | 14.79B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.63B | -557.00M | 2.86B | 4.75B | 2.58B | Operating Cash Flow |
0.00 | 7.36B | 3.33B | 6.13B | 6.80B | 4.11B | Investing Cash Flow |
0.00 | -3.29B | -4.20B | -3.27B | -1.19B | -2.00B | Financing Cash Flow |
0.00 | -423.00M | -1.68B | -1.90B | -702.00M | -4.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥26.81B | 6.42 | 2.75% | 5.49% | 14.96% | ||
80 Outperform | ¥18.37B | 5.98 | 4.43% | 7.08% | -1.44% | ||
73 Outperform | ¥34.74B | 7.75 | 3.87% | 0.63% | 24.41% | ||
65 Neutral | ¥17.08B | 12.11 | 2.38% | 3.22% | 7.14% | ||
65 Neutral | $8.94B | 14.98 | 4.76% | 203.76% | 3.54% | -2.49% | |
61 Neutral | ¥28.26B | 24.19 | 3.15% | -9.02% | -39.11% |